A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses

David C. Jackson, Lorena E. Brown, Thuy T. Le et al.|Proceedings of the National Academy of Sciences|2004

Cited by 235